skip to navigation

Resources

Featured Resources

XLSX

Advocacy Tool and Article: Estimating the Cost of Blindness

Ophthalmic Epidemiology published two simple cost models developed by Eckert et al.1 that estimate the annual loss of… More »

PDF

ICO Endorses Global Ban on Consumer Fireworks

The ICO endorses a global ban on consumer fireworks and encourages ICO member societies to advocate for legislation to ban… More »

URL

Global Statement on Diabetes and Eye Heath

The ICO, International Diabetes Federation, World Council of Optometry, and International Agency for the Prevention of… More »

Topic Subspecialty Rating Date ICO Member Resource Name & Description Author

Advocacy/Vision 2020

Diabetic Eye Care

not yet rated March 16, 2017 Diabetic Retinopathy: A Position Statement by the American Diabetes Association

Diabetic retinopathy diagnostic assessment and treatment options have improved dramatically since the 2002 American Diabetes Association Position Statement. These improvements include the widespread adoption of optical coherence tomography to assess retinal thickness and intraretinal pathology and wide-field fundus photography to reveal clinically silent microvascular lesions. Treatment of diabetic macular edema is now achieved by intravitreous injection of anti–vascular endothelial growth factor agents, and the same drugs are now used for proliferative diabetic retinopathy. Improvements in medications and devices for the systemic therapy of diabetes have also improved the ability of patients to optimize their metabolic control. This Position Statement incorporates these recent developments for the use of physicians and patients.


URL | Save to My ICO
American Diabetes Association

Stay connected:         Follow us on Instagram

Web site design and web development by D3 Solutions